Non-current Assets:
Property and equipment, net of
accumulated depreciation of
$1,350,913 and $1,003,802,
respectively 2,619,965 2,625,216
Intangible assets, net of accumulated
amortization of $465,132 and
$221,715, respectively 2,432,253 2,063,252
Advances for purchases of
intangible assets 6,840,631 807,345
Deferred tax assets 413,890 187,509
Total Non-current Assets 12,306,739 5,683,322
TOTAL ASSETS $66,824,681 $43,706,320
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
Trade accounts payable $505,704 $297,299
Accrued expenses 47,450 261,301
Accrued taxes payable 946,948 311,009
Other payables 130,652 86,161
Advances from customers 674,135 261,583
Short-term notes payable -- 2,693,428
Total Current Liabilities 2,304,889 3,910,781
Research and development commitments 36,381 34,181
Total Liabilities 2,341,270 3,944,962
Stockholders' Equity:
Common stock, $0.001 par value,
60,000,000 shares authorized,
42,278,938 and 37,278,938 shares
issued and outstanding, respectively 42,279 37,279
Additional paid-in capital 21,062,586 11,678,606
Foreign currency translation
adjustment
'/>"/>
| SOURCE China Pharma Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved |